Biogen receives breakthrough therapy designation for felzartamab, shares edge up
Investing.com — Shares in Biogen (NASDAQ:BIIB) were trading marginally higher after the company said its investigational antibody felzartamab had received...
Read moreInvesting.com — Shares in Biogen (NASDAQ:BIIB) were trading marginally higher after the company said its investigational antibody felzartamab had received...
Read moreNEW DELHI (Reuters) – Ratan Tata, the chairman emeritus of one of India’s biggest conglomerates, Tata Sons, is in critical...
Read moreInvesting.com — Tesla (NASDAQ:TSLA) is due to unveil plans for its long-awaited robotaxi offering this week in an event that...
Read moreInvesting.com — Hedge funds are no longer buying dips ahead of macroeconomic catalysts, Barclays strategists revealed in a recent note....
Read moreInvesting.com — According to a recent note from KeyBanc Capital Markets, the initial feedback for Apple (NASDAQ:AAPL)’s iPhone 16 suggests that...
Read moreInvesting.com – Saudi Arabia stocks were higher after the close on Tuesday, as gains in the Industrial Investment, Real Estate...
Read moreInvesting.com — Shares of Otis Worldwide Corporation (NYSE:OTIS) were down 3% in pre-open trade on Tuesday after the stock was...
Read moreAs traders approach another pivotal week for financial markets, a series of crucial decisions and economic data releases that could...
Read moreInvesting.com – Saudi Arabia stocks were higher after the close on Monday, as gains in the Financial Services, Transport and...
Read moreBy Seher Dareen (Reuters) -Chevron is selling its assets in Athabasca Oil (OTC:ATHOF) Sands and Duvernay Shale to Canadian Natural...
Read moreCopyright © 2025 Insightfulword.com. All Rights Reserved.